학술논문

ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
Document Type
Article
Source
American Journal of Clinical Nutrition; May2021, Vol. 113 Issue 5, p1168-1176, 9p, 6 Charts
Subject
COGNITION disorders
STATINS (Cardiovascular agents)
DOCOSAHEXAENOIC acid
STATISTICS
CONFIDENCE intervals
TIME
COGNITION
CORONARY disease
PSYCHOLOGY of movement
TREATMENT effectiveness
NEUROPSYCHOLOGICAL tests
EICOSAPENTAENOIC acid
OMEGA-3 fatty acids
DESCRIPTIVE statistics
DATA analysis
SECONDARY analysis
Language
ISSN
00029165
Abstract
Copyright of American Journal of Clinical Nutrition is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)